Stock SAROJA SAROJA PHARMA INDUSTRIES INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Saroja Pharma Industries India Limited

Equities

SAROJA

INE0PCL01011

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 11:50:49 2024-07-15 pm EDT 		5-day change 1st Jan Change
42.7 INR +2.40% Intraday chart for Saroja Pharma Industries India Limited +0.71% -19.43%
May. 29 Saroja Pharma Industries India Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 170.8 366.6 556.3 501.9
EBITDA 1 3.817 13.36 21.85 27.8
EBIT 1 3.771 13.15 21.44 27.14
Operating Margin 2.21% 3.59% 3.85% 5.41%
Earnings before Tax (EBT) 1 2.151 10.35 15.79 14.92
Net income 1 1.609 7.313 11.4 10.61
Net margin 0.94% 1.99% 2.05% 2.11%
EPS 2 12.38 56.25 3.884 3.610
Free Cash Flow - -14.41 -49.86 -28.35
FCF margin - -3.93% -8.96% -5.65%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 9/3/21 9/3/21 8/23/22 6/15/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 16.2 29.8 58.4 98.2
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 4.249 x 2.233 x 2.671 x 3.535 x
Free Cash Flow - -14.4 -49.9 -28.3
ROE (net income / shareholders' equity) - 128% 46% 23.3%
ROA (Net income/ Total Assets) - 12.6% 11.3% 9.21%
Assets 1 - 58.01 101 115.2
Book Value Per Share 2 15.70 72.00 13.70 17.30
Cash Flow per Share 2 5.790 0.3200 0.9000 1.240
Capex 1 0.23 0.54 3.02 37.3
Capex / Sales 0.13% 0.15% 0.54% 7.42%
Announcement Date 9/3/21 9/3/21 8/23/22 6/15/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SAROJA PHARMA INDUSTRIES INDIA LIMITED Stock Saroja Pharma Industries India Limited
-19.43% 2.01M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+63.05% 856B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.42% 631B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.78% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.52% 325B
ABBVIE INC. Stock AbbVie Inc.
+8.43% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.19% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+5.81% 234B
NOVARTIS AG Stock Novartis AG
+16.77% 226B
AMGEN INC. Stock Amgen Inc.
+14.63% 177B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SAROJA Stock
  4. Financials Saroja Pharma Industries India Limited